

Currently, one-third of the US population has been diagnosed with myopia and it is thought that by 2050, 50% of the population will be myopic. As myopia increases the risk for eye diseases increases, such as retinal detachment, myopic macular degeneration, glaucoma, and cataracts. The goal of myopia management is to slow eye growth and reduce the associated risks.

There are 3 different therapies that have been studied and shown to slow the progression of myopia. The doctors at Dobbins & Letourneau Eyecare prescribe all 3 therapy options and can recommend which option might be best for your child.
This is a brief overview of each therapy. More detailed information can be found on the website and in future blog posts. If you have any questions, please contact our office.

